SPC474
Rezafungin eða lyfjafræðilega viðunandi salt þar af, sérstaklega rezafunginasetat
Status:
VeittApplication date:
19.6.2024Application published:
15.7.2024Grant published:
15.12.2025
Max expiry date:
1.3.2037Medicine name:
RezzayoMedicine for children:
No
Timeline
Today
19.6.2024Application
15.7.2024Publication
15.12.2025Registration
1.3.2037Expires
Marketing license
IS authorization number:
EU/1/23/1775Date:
29.12.2023
Foreign authorization number:
EU/1/23/1775Date:
22.12.2023
Owner
Name:
Napp Pharmaceutical Group LimitedAddress:
Unit 191 Cambridge Science Park, Milton Road, CB4 0GW Cambridge GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2680873
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025